BiondVax Pharmaceuticals ...

NASDAQ: BVXV · Real-Time Price · USD
1.36
0.01 (0.74%)
At close: Sep 06, 2023, 9:59 PM

BiondVax Pharmaceuticals Cash Flow Statement

Financials in ILS. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-5.8M -39.98M
Depreciation & Amortization
562K 2.42M
Stock-Based Compensation
1.6M 8.9M
Other Working Capital
446K 3.94M
Other Non-Cash Items
-3.9M -970K
Deferred Income Tax
n/a -33K
Change in Working Capital
271K 5.18M
Operating Cash Flow
-7.26M -24.48M
Capital Expenditures
-836K -430K
Cash Acquisitions
n/a n/a
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
n/a 69K
Investing Cash Flow
-836K -361K
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
6.78M 67.78M
Financial Cash Flow
6.78M 67.78M
Net Cash Flow
-3.3M 44.62M
Free Cash Flow
-8.1M -24.91M